Welcome to Marie Moreau
from France!
Welcome to Marie Moreau
from France!
On 1st October 2026, Marie Moreau joined PharMarketing GDPR Life Sciences as Consulting Director for Privacy, Quality and Good Clinical Practices. She brings 26 years of experience in roles such as Data Protection Officer, Clinical Operations Director and Quality Assurance Director at a French Scientific Society, the French Federation of Digestive Oncology (‘FFCD’).
Marie has a Master II (DEA) in cellular and molecular biology from the University of Dijon in Burgundy, France. She brings a deep knowledge in academic research, ISO 9001, audits, Quality Management Systems, Clinical Research and partnerships with Industrial organizations and CROs internationally.
Marie will be a key pillar in our Consulting company, supporting our clients in becoming compliant with GDPR/Privacy, GCP and implementing Quality Management Systems as well as conducting audits.
Welcome to the Dream Team, Marie!
Examples of Non-Compliance
with Health Data Privacy
Data Protection Authorities ('DPAs') published several decisions related to the processing of health data in the past months.
Such decisions shed light on the key measures to implement to stay compliant with privacy (and healthcare) laws and avoid a critical finding.
For each decision, we propose key takeaways: use them as ideas and guidelines for your own organisations: check that such measures are implemented at your organisation, and if not, talk to your management (or talk to us!).
Many thanks to GDPR hub NOYB and to IAPP for all this valuable information!
Finland
Fact:
The Finish Data Protection Authority (DPA) fined a healthcare service provider €33,000 for unlawfully disclosing personal data on customers’ therapy appointments to Google, Meta, and Microsoft due to external tracking on its website. Read more or edit on GDPRhub…
Takeaway:
Website tracking (e.g. Google Analytics) allows Google to infer that the patient booking the appointment has a certain pathology. And if the pathology is serious (e.g. leukemia), the disclosure could have an important impact on the private life of the patient if for example the data is sold by a data broker* and the patient’s bank learns he/she has leukemia.
( * ) see article published by the Washington post on the collection of geolocation data of patients when at a doctor’s meeting and the sale of such data by data brokers.
Fact:
The Finish DPA fined a plastic surgery clinic €20,200 for a failure to comply with a DPA order to provide a data subject access to their patient records. Read more or edit on GDPRhub…
Takeaway:
The right to access is a fundamental right that all people in the world have. And the organization (here the plastic surgery clinic) must provide a copy of the personal data within one month. The only situation where the plastic surgery clinic could refuse to provide a copy of its personal data to a patient is if it would have an impact on the private life of other people, or an impact on the business of the clinic.
Iceland
Fact:
The DPA issued a reprimand against an employee of a hospital for conducting unauthorised searches of a data subjects medical records. The DPA considered the employee to be a controller because they exceeded their access privileges. Read more or edit on GDPRhub…
Takeaway:
In this case, the employee of the hospital broke 2 laws:
Fact:
The social services department requested a service provider to provide numerous information concerning disabled people for which it received funds. The DPA held that requesting this information would be disproportionate and not sufficiently transparent. Read more or edit on GDPRhub...
Takeaway:
The principle of minimization of the GDPR states that organizations should always use the less possible personal data for their personal data processings. This is especially important when processing personal data from disabled people, who are considered as vulnerable data subjects by the GDPR and other privacy laws.
Italy
Fact:
Italy's data protection authority, the Garante, issued a 7 million euro fine to IQVIA Solutions after a routine inspection of their services uncovered a data breach which resulted in the disclosure of 3,780 patients’ data. The Garante stated that the company allegedly processed sensitive health data of 1 million patients to share with pharmaceutical companies for research purposes.
The DPA held that the data was not sufficiently anonymized not to be personal data and were processed without a legal basis. Read more or edit on GDPRhub…
Takeaway:
Providers of patient data should ask their local DPA to confirm they have suffisiently anonymized (or pseudonymized) patient data for the objective of the personal data processing.
NB: Another provider of patient data was already fined for the same reason by the French DPA, the CNIL, several months ago.
Romania:
Fact:
The provider of an event platform was fined RON 31,451 (€6,000) after a cyberattack exposed personal data stored on a testing server. According to the DPA, a failure of not using mock data instead of real data facilitated the data breach. Read more or edit on GDPRhub…
Takeaway:
Never put actual personal data on a test server.
United States
Fact:
As reported by the Washington Post on 27 October 2026, many patients receive spam emails with ads for fake cures linked to their pathology. when patients are sitting in a hospital, an abortion clinic, or an Alcoholics Anonymous meeting in a church basement, the location data emitted from their mobile phones are captured. Then patients’ health data are derived from their location data by data brokers who then resell their data to advertisers. This isn’t covered by the Health Insurance Portability and Accountability Act (HIPAA), which protects only patients data collected during care.
Advocacy groups are urging U.S. lawmakers to prevent data brokers from accessing sensitive health and location data for advertising purposes due to concerns that patients could be vulnerable to targeted advertisements for potentially harmful products and services.
Read article from the Washington Post: https://www.washingtonpost.com...
Takeaway:
At this time, US privacy laws protect only consumers when they buy something in a shop or on the internet. And HIPAA protects only patients data collected during care. To protect citizens and patients in all other situations, the US need to enable a privacy law similar to what is in place in countries like EU/EEA, UK, Switzerland, China, Brazil and others: US citizens should ask their Representatives at the Congress to draft such a law.
Privacy News
from around the Globe:
Privacy News from around the Globe:
Global
New OECD report examines neural data governance issues
While innovative neurotechnologies stand to offer a wide range of medical and scientific breakthroughs, the sensitive nature of brain data, or "neurodata," is driving a fairly nascent movement pushing for guardrails on how such data can be used in research, medical and commercial applications. The Organisation for Economic Co-operation and Development ('OECD') recently unpacked key takeaways from its new paper outlining
key data governance concerns related to neurodata while also offering
policy recommendations for ensuring user privacy.
Full story
OECD releases Global Repository for Privacy Enhancing Technologies
The Organisation for Economic Co-operation and Development released its Global Repository for Privacy Enhancing Technologies to guide organizations through the applicable legal obligations and guidance for implementing PETs. The repository also details technical standards, appropriate use cases, differential privacy tools and key steps to effectively deploy PETs. See repository here: https://www.oecd.org/en/toolki...
Argentina
A comprehensive reform proposal of the Personal Data Protection Law was introduced to the Argentine Congress. Read the article from Allende and Brea https://allende.com/privacidad-y-ciberseguridad/se-reintroduce-en-el-congreso-el-proyecto-de-reforma-integral-del-regimen-argentino-de-proteccion-de-datos-personales-08-12-2026/?mkt_tok=MTM4LUVaTS0wNDIAAAGk2ej8l3pNKhh9r7XyUO8Ervij-DxzvwODnBsAnbh2dyfn2Fi1w_O6JXar1l7VsYnNNXmu0QZcda-9k5M-yoqkBMA2i6y30X2SFm_34Ga1SWcY
Read the project of law: https://www.hcdn.gob.ar/proyec...
Australia
The
Office of the Australian Information Commissioner released resources detailing
transparency obligations for
AI and automated decision-making systems to ensure compliance with the Privacy and Other Legislation Amendment Act.
Organizations have until 10 Dec. to comply with the Australian Privacy Principles transparency amendments by including information within their privacy notices on what personal data is collected, processed and used to make decisions about consumers.
Full story
Canada
29 October 2026: Canada’s federal, provincial, and territorial privacy commissioners and ombuds call for the responsible use of artificial intelligence in health and health research. Read here: https://www.priv.gc.ca/en/opc-...
EU
* EU Biotech Act might make local Privacy guidelines for Clinical Trials illegal:
Article 93.7 of the Draft Biotech Act states:
“By derogation from Article 9(4) of Regulation (EU) 2016/679, Member States may not maintain or introduce further conditions, including limitations, with regard to the processing of personal data, including genetic data or data concerning health in the context of clinical trials carried out in accordance with this Regulation”.
According to this provision, countries will not be able to rely art. 9.4 GDPR to introduce local rules for e.g. on legal basis, formalities, methodologies etc. So if this comes into force, only the Biotech Act and the CTR will be applicable; it is important to note that this article was not contested by the EDPB/EDPS Joint Opinion 3/2026 on the proposed Biotech Act.
* 18 September 2026 : the European Commission published the
Commission Implementing Regulation (EU) 2026/2098 laying down
the minimum metadata elements and their characteristics to be provided by health data holders for dataset descriptions for the
secondary use of electronic health data under Article 77(4) of Regulation (EU) 2025/327 establishing the
European Health Data Space.
These requirements help
build the national catalogs of datasets, which will be
connected at the European level. This is a key operational step for implementing the
EEDS: making health data easier to identify and access, in a harmonized and secure framework, to support research and innovation.
Read the Commission Implementing Regulation (EU) 2026/2098 of 18 September 2026 :
https://eur-lex.europa.eu/eli/...
* EDPS:
A new cross-border infrastructure, HealthData@EU, will connect national bodies so that health data can be reused across the EU. On 8 October, the European Data Protection Supervisor (EDPS) issued Formal Comments on the draft Commission Implementing Regulation setting out how the infrastructure will work. Read EDPS comments: https://www.edps.europa.eu/dat...
France
* The decree of October 26, 2026, published in the Official Journal on October 28 (JORF No. 0252, text No. 45) provides 3 templates to use to get the written consent of patients when genetic exams are performed for medical objectives.
Read the decree here: https://www.legifrance.gouv.fr...
* CNIL issues guide on email address reconstruction
France's data protection authority, the Commission nationale de l'informatique et des libertés, published guidelines on how the EU General Data Protection Regulation applies to email addresses reconstructed via publicly-available data. The guide outlines the practice and purpose of reconstructed addresses while covering what constitutes lawful reconstruction, including how the data was made accessible and the intended purpose for retrieving the address.
Germany
Germany's digital authorities release post-quantum cryptography guidelines
Latvia
Latvia's DVI issues guidance on health data collected on personal devices
Latvia's Data State Inspectorate issued
guidance for health organizations, noting they must implement
appropriate data collection and deletion standards when processing patient data from photographs or digital test results on personal or internal devices. The DVI also advised patients have the right to request that their medical information is deleted from the organization's systems; however, "if a medical institution is required to retain specific documents in accordance with regulations, a patient's request does not mean that the entire medical history must be deleted."
Full story
Lithuania
Lithuania's DPA released guidance for assessing the severity of personal data breaches: read here: https://vdai.lrv.lt/lt/naujien...
Malaysia
Malaysia to introduce AI governance legislation in 2027
Netherlands
The Netherlands Authority for Consumers and Markets released
EU Data Act guidance for organizations considering switching their cloud providers. The ACM said changing cloud providers "must be quick, easy, and free of charge" under the
Data Act.
Full story
Poland
Poland's DPA releases breach reporting guidance
South Korea
South Korea initiates adequacy review with UK
Spain
Spain's AEPD releases guide on algorithmic transparency in employment decisions
Spain's data protection authority, the Agencia Española de Protección de Datos, issued
guidance on how to best comply with the country's new rules on employers' transparent use of algorithms and automated decision-making technology in employment decisions. The guide covers general best practices and details on how
Royal Decree 723/2026 interacts with the EU General Data Protection Regulation. Covered entities must consider compliance requirements under both laws as it relates to AI use in hiring, promotions, schedule making, performance tracking and more.
Full story
UK
* The UK Research and Innovation (UKRI) has published its new research data policy. The policy will apply to all research funded by the research councils, UKRI-wide schemes and some activities funded by Innovate UK and Research England. It will apply to new funding opportunities published on or after 1 April 2027. It replaces multiple policies and principles with a single, updated policy framework. The new policy will help to ensure that publicly funded research data is findable, accessible, interoperable and reuseable (FAIR). Read more: https://www.ukri.org/news/ukri...
* The U.K. AI Security Institute published a list of technical best practices for ensuring safe frontier AI development. Full story
* NHS has implemented a Research Secure Data Environment (SDE) Network. Read the blog from Dr Paul Mills, HRA Confidentiality Advice Service Manager: https://www.hra.nhs.uk/about-u...
* Read also the article from Dr Alison Knight, Data and Privacy Specialist and Research Data Policy Lead on when information is personal data, how identifiability should be assessed and how these principles apply in research settings, including trusted research environments (TREs) and secure data environments (SDEs): https://www.hra.nhs.uk/about-us/news-updates/our-response-to-the-ico-anonymisation-and-pseudonymisation-consultation/
* The UK government has accepted all 44 recommendations of the National Commission into the Regulation of AI in Healthcare: read https://www.hra.nhs.uk/about-us/news-updates/government-response-to-ai-in-healthcare-recommendations-published/
United States
* The
U.S. National Institute of Standards and Technology (‘NIST’) seeks
feedback on updated cybersecurity guide for executives. he deadline for public feedback is 4 Dec.
Full story
* NIST released post-quantum computing roadmap, read here https://www.nist.gov/news-even...:

Yes: because of article 93.7 of the Draft Biotech Act, see article above
2. US Privacy laws cover Protected Health Information (PHI) in all situations:
No: US privacy laws protect only PHI collected during care; they don't protect PHI derived from a patient's location data when such patient is waiting at the oncology department of an hospital
Dear Sir/Madam,
Thank you for contacting us.
We will get back to you as soon as possible.
Best regards,
PharMarketing
PharMarketing, a business unit of Silicon Marketing SASU
8 rue Roublot - 94120 Fontenay-sous-Bois - France
VAT Number FR38799016977
Subscribe to our free GDPR Life Sciences Newsletter
NB: we reserve the right to accept or deny requests to receive our Newsletter
Copyright PharMarketing 2013-2026 © All rights reserved.